Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like antipsychotics, can be debilitating. The impact of TD, however, may go beyond ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching 'The Other TD' campaignTD is a chronic movement disorder impacting one in four people who take certain pr ...

This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaign; TD is a chronic movement disorder impacting one in four ...

ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...

The Association of Movement Disorder Advanced Practice Providers (AMDAPP) is working to increase awareness and understanding of the role of Advanced Practice Providers and Advanced Nurses within the ...

Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps of the developing human brain. The atlas captures nearly every cell type, ...

A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...

Osteoarthritis is now affecting younger adults, even in their 20s and 30s, moving beyond its traditional association with the elderly. Factors like po ...

Mother Daphne Graskewicz-Prado of Southern Illinois told Newsweek: “I wasn’t going to accept the terminal diagnosis.” ...

Researchers and families unite to address Huntington's disease, exploring innovative therapies and fostering connections at ...

Neurocrine Biosciences (NASDAQ: NBIX) delivered a decisive earnings beat in Q3, posting adjusted EPS of $2.17 against ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...